2019 Environment, Society and Governance Report

Company: SH PHARMA (2607)
Year: 2019
Published: 2020-05-19
Status: Processed
View Report

Extracted ESG KPIs

KPIs are organized by ESG aspects.

The types of emissions and respective emissions data.

Indicator Unit 2019 Report Pages
Amount of COD in wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 13.18 116
Amount of COD in wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 4.76 116
Amount of N-NH3 in wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 0.25 116
Amount of N-NH3 in wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 0.64 116
Amount of nitrogen oxide in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory kg 496.61 116
Amount of nitrogen oxide in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary kg 1210.36 116
Amount of particulate matter in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory kg 1045.86 116
Amount of particulate matter in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary kg 173.89 116
Amount of sulfur dioxide in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory kg 0.61 116
Amount of sulfur dioxide in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary kg 92.78 116
Number of VOCs online monitoring equipment installed (Shanghai SPH Zhongxi Pharmaceutical Co., Ltd.) sets 2 112
Number of VOCs treatment facilities improved/replaced (Shanghai SPH Zhongxi Pharmaceutical Co., Ltd.) sets 2 112
Number of sets of VOCs online monitoring equipment networked to municipal and district monitoring platforms (Shanghai SPH Zhongxi Pharmaceutical Co., Ltd.) 2 105
Shanghai Pharmaceutical Minhang Co., Ltd. - Monitoring data compliance all up to standards 106
Shanghai Sine Jinzhou Pharmaceutical Co., Ltd. - Frequency of online monitoring for exhaust gas, industrial sewage, rainwater, domestic sewage every year 106
Shanghai Sine Jinzhou Pharmaceutical Co., Ltd. - Monitoring data compliance all up to standards 106
Total amount of non-methane hydrocarbon in exhaust gas emitted, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory kg 3.96 116

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 Report Pages
Direct greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 385.21 116
Direct greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 809.82 116
Greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 33198.1 116
Greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 3048.96 116
Indirect greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 32812.89 116
Indirect greenhouse gas emissions, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 2239.13 116

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 Report Pages
Amount of hazardous waste disposed, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 112.21 116
Amount of hazardous waste disposed, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 22.61 116
Amount of hazardous waste produced, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 112.21 116
Amount of hazardous waste produced, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 23.61 116
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. - Daily capacity of sewage treatment tonnes of sewage 300 106

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 Report Pages
Amount of general solid waste disposed, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 373.98 116
Amount of general solid waste disposed, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 27 116
Amount of general solid waste produced, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 437.06 116
Amount of general solid waste produced, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 51 116
Amount of general solid waste utilized, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 63.08 116
Amount of general solid waste utilized, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 28.8 116

Description of emissions target(s) set and steps taken to achieve them.

Indicator Unit 2019 Report Pages
Investment in improving and replacing VOCs treatment facilities (Shanghai SPH Zhongxi Pharmaceutical Co., Ltd.) million RMB 3 112

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Indicator Unit 2019 Report Pages
Shanghai Pharmaceutical Minhang Co., Ltd. - Daily capacity of sewage treatment station tonnes 200 106

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2018 2019 Report Pages
Comprehensive energy consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne of standard coal 11671.18 116
Comprehensive energy consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne of standard coal 1123.57 116
Diesel fuel consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory tonne 31.7 116
Diesel fuel consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 4 116
Electricity consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory 10000 kWh 2627 116
Electricity consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary 10000 kWh 215.94 116
Gasoline consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 3.3 116
Liquefied petroleum gas consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary tonne 5 116
Natural gas (gaseous) consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory 10000 cubic meters 1.51 116
Natural gas (gaseous) consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary 10000 cubic meters 35.45 116
Outsourcing thermal power consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory million kJ 121678.2 116
Travel cost savings from video conferences million RMB 5.44 157

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2019 Report Pages
Amount of wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory 10000 tonnes 21.26 116
Amount of wastewater discharged, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary 10000 tonnes 5.23 116
Water consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., General Factory 10000 tonnes 23.63 116
Water consumption, Shanghai SPH Sine Pharmaceutical Laboratories Co., Ltd., No. 2 Subsidiary 10000 tonnes 5.82 116

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Indicator Unit 2019 Report Pages
Environmental protection investment, Changzhou Pharmaceutical Factory Co., Ltd. million RMB 8.215 113
Estimated input for 15 improvement plans for clean production, Changzhou Pharmaceutical Factory Co., Ltd. million RMB 0.95 113
Estimated input for 6 improvement plans for VOCs 'one policy for one enterprise', Changzhou Pharmaceutical Factory Co., Ltd. million RMB 0.15 113
PH New Asia Pharmaceutical Co., Ltd. (New Asiatic Pharmaceutical Factory) - Monitoring data compliance all up to standards 106
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. - Monitoring data compliance all up to standards 106
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. - Number of exhaust gas treatment facilities established facilities a number 106
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. - Number of sewage treatment stations stations 2 106

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Indicator Unit 2017 2018 2019 Report Pages
Age composition - Aged 19 and under % 23.48 21.81 21 88
Age composition - Aged 20-29 % 32.92 35.66 36.37 88
Age composition - Aged 30-39 % 25.35 25.16 25.81 88
Age composition - Aged 40-49 % 15.26 14.5 14.37 88
Age composition - Aged 50-59 % 2.39 2.53 2.25 88
Age composition - Aged 60 and above % 0.6 0.34 0.2 88
Bachelor degree (Education composition) person 8558 10616 11905 89
Doctor degree (Education composition) person 53 73 80 89
Employee structure - Management % 3.58 3.39 3.38 89
Employee structure - Marketing % 11.62 12.75 13.04 89
Employee structure - Others % 40.61 41.63 41.9 89
Employee structure - Production % 33.24 31.11 29.79 89
Employee structure - Technology % 10.95 11.12 11.88 89
Higher vocational college (Education composition) person 12110 13289 15220 89
Master degree (Education composition) person 960 1229 1438 89
Number of new 'love cabins' built for employees cabins 6 86
Number of registered members of Shanghai Labour Union members 17200 85
Percentage of total members of enterprises in Shanghai insured under special insurance plan % 92.5 85
Sex composition - Female person 20946 24085 24255 88
Sex composition - Male person 21290 23505 23523 88
Technical secondary (Education composition) person 10985 11471 12525 89
Total assets RMB billion 137.026 12
Total number of employees person 42236 47590 47778 88
Total number of on-post employees person 35540 40399 40535 88
Total number of other employees person 6696 7191 7243 88

Employee turnover rate by gender, age group and geographical region.

Indicator Unit 2019 Report Pages
Operating income RMB billion 186.566 12

Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.

Indicator Unit 2017 2018 2019 Report Pages
Total compensation for accidental or disease death (2 members) RMB 68000 85
Work safety accidents or work-related accidents in the year (number of accidents) 20 19 17 84

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Indicator Unit 2017 2018 2019 Report Pages
Incidence rate of occupational diseases 1 84
Occupational health-related investment RMB 0'000 3555.97 5768.37 6618.11 84
Safety education and training (number of persons) Person 60078 69102 86314 84
Safety education and training (number of times) Times 1881 1785 1824 84

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Indicator Unit 2019 Report Pages
Digestion Metabolism - Apply for clinical trial SPH4480 20
Lean Six Sigma Black Belt Theory employees certified employees 145 29
Lean Six Sigma Black Belt employees certified employees 13 29
Lean Six Sigma Green Belt Theory employees certified employees 1876 29

The average training hours completed per employee by gender and employee category.

Indicator Unit 2019 Report Pages
Average duration of video conferences hours 2.33 157
Total duration of video conferences hours 539 157

Number of products and service related complaints received and how they are dealt with.

Indicator Unit 2019 Report Pages
Anti-tumor drugs - Apply for clinical trial SPH3261 20
Anti-tumor drugs - Clinical phase I CD30-DM1 Antibody, SPH3384, SPH1188-11, Humanized CD20 antibody, HER2 compound antibody, T-DM1 20
Immunosuppressor - Clinical phase II LLDT-8 - Rheumatoid Arthritis, LLDT-8 - AIDS 20
Number of generic drugs products added and approved for production products 3 10
Number of generic drugs products added and declared for production products 2 10
Number of gravely ill members compensated by end of year members 33 85
Number of gravely ill members with settled claims under insurance plan members 42 85
Number of large major varieties with sales exceeding 100 million products 35 10
Number of products with sales between 500 million and 1.5 billion products 8 10
Number of products with sales exceeding 1.5 billion product 1 10
Number of video conferences held 227 157
Proportion of products developing rapidly (more than 50% in products including Perhexiline, Captopril Tablets, Yuxuebi Capsules and Granules, Salbutamol Inhaler, Trypsin for Injection, etc.) more than 50% 10

Description of practices relating to observing and protecting intellectual property rights.

Indicator Unit 2019 Report Pages
Lean Six Sigma Projects launched projects 156 29

Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.

Indicator Unit 2019 Report Pages
Owners' equity RMB billion 41.659 12

Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).

Indicator Unit 2017 2018 2019 Report Pages
Drugs for treatment of cardiovascular and cerebrovascular diseases - Clinical phase I Salvianolic acid A for injection 20
Drugs for treatment of cardiovascular and cerebrovascular diseases - Clinical phase II SPH3127 20
Other (Education composition) person 9570 10912 6610 89
Per capita sales income (Efficiency indicator) RMB0000 305.35 332.57 374.9 89

Resources contributed (e.g. money or time) to the focus area.

Indicator Unit 2019 Report Pages
Compensation per gravely ill member RMB 20000 85
Funds allocated by Group's trade union to Fahrenheit Pharmacy for summer and winter supplies RMB 100000 85
Number of 'Love Stations for Outdoor Employees' after addition by Fahrenheit Pharmacy stations 40 85
Number of members compensated under 'Love and Help' programme members 32 85
Total compensation under 'Love and Help' programme RMB 834000 85

The types of emissions and respective emissions data.

Standard Indicator Unit 2019
Airborne Particulate Matter (PM) Emissions kg 1219.75
NOâ‚“ Emissions kg 1706.97
SOâ‚“ Emissions kg 93.39

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019
Direct GHG Emissions (Scope 1) tonne 1195.03
Indirect Energy Emissions (Scope 2) tonne 35052.02
Total GHG Emissions tonne 36247.06

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019
Hazardous Waste Disposed tonne 134.82
Total Hazardous Waste tonne 135.82

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019
Non-Hazardous Waste (Domestic Waste) tonne 51
Non-Hazardous Waste Disposed tonne 373.98
Non-Hazardous Waste Recycled tonne 28.8

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Standard Indicator Unit
Amount of Hazardous Waste Disposed tonne

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019
Diesel Fuel Consumption tonne 35.7
Gasoline Consumption tonne 3.3
LPG Consumption tonne 5
Natural Gas Consumption 10000 cubic meters 36.96
Purchased Electricity 10000 kWh 2842.94
Purchased Heating million kJ 121678.2
Total Energy Consumption tonne of standard coal 12794.75
Total Indirect Energy Consumption 10000 kWh 2842.94

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2019
Total Wastewater Discharge 10000 tonnes 26.49
Total Water Withdrawal 10000 tonnes 29.45
Water Consumption 10000 tonnes 29.45

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Standard Indicator Unit
Packaging Materials Consumed set

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Standard Indicator Unit 2019
Total Investment in Ecological Restoration million RMB 0.95

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Standard Indicator Unit 2017 2018 2019
Number of Bachelor's Degree Employees person 8558 10616 11905
Number of Doctoral Degree Employees person 53 73 80
Number of Employees Aged 30-50 person 17213 19213 19213
Number of Employees Aged Above 50 person 1200 1036 1152
Number of Employees Aged Below 30 person 23823 27341 27413
Number of Female Employees person 20946 24085 24255
Number of Male Employees person 21290 23505 23523
Number of Master's Degree Employees person 960 1229 1438
Number of Total Employees person 42236 47590 47778
Percentage of Bachelor's Degree Employees % 20.27 22.32 24.91
Percentage of Doctoral Degree Employees % 0.13 0.15 0.17
Percentage of Employees Aged 30-50 % 40.61 40.66 40.18
Percentage of Employees Aged Above 50 % 3 2.87 2.45
Percentage of Employees Aged Below 30 % 56.4 57.47 57.37
Percentage of Female Employees % 49.57 50.59 50.77
Percentage of Male Employees % 50.43 49.41 49.23
Percentage of Master's Degree Employees % 2.27 2.58 3.01

Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.

Standard Indicator Unit 2019
Number of Fatalities as a Result of Work-related Injuries 2

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Standard Indicator Unit 2017 2018 2019
Investment in Work Safety RMB 0'000 3555.97 5768.37 6618.11
Number of People Receiving Training on Work Safety Person 60078 69102 86314
Number of Safety knowledge lectures Times 1881 1785 1824

The average training hours completed per employee by gender and employee category.

Standard Indicator Unit 2019
Average Training Hours per Employee hours 2.33
Total Training Hours hours 539

Resources contributed (e.g. money or time) to the focus area.

Standard Indicator Unit 2019
Investment in Targeted Poverty Alleviation RMB 565920
Total Social Investment RMB 837500